Nasopharyngeal carcinoma

Lancet

Volumn 350, Issue 9084, 1997, Pages 1087-1091

  Vokes, Everett E ^a,b   Liebowitz, David N ^a   Weichselbaum, Ralph R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; EPIRUBICIN;

CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030770175     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)07269-3     Document Type: Review

References (30)

1. Altun M, Fandi A, Dupuis O, Cvitkovic E, Krajina Z, Eschwege F. Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects. Int J Radiat Biol Phys 1995; 32: 859-77.
2. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Medical progress in head and neck cancer. New Engl J Med 1993; 383: 184-94.
3. Henderson BE, Louie E, Jing JSH, Buell P, Gardner MB. Risk factors associated with nasopharyngeal carcinoma. New Engl J Med 1976; 295: 1101-06.
4. Yu MC, Mo C-C, Chong W-X, Yeh F-S, Henderson BE. Preserved foods and nasopharyngeal carcinoma: a case-control study in Guangxi, China. Cancer Res 1988; 48: 1954-59.
5. Rickinson AB, Kieff E. Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology. 3rd edn. Philadelphia: Lippincott-Raven, 1996; 2397-446.
6. Kieff E. Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology. 3rd edn. Philadelphia: Lippincott-Raven, 1996; 2343-96.
7. Fahraeus R, Rymo L, Rhim JS, Klein G. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 1990; 345: 447-49.
8. Dawson CW, Rickinson AB, Young LS. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiatio. Nature 1990; 344: 777-80.
9. Mosiaios G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 1995; 80: 389-99.
10. Zeng Y, Zhang LG, Wu YC, et al. Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive in Wuzhou City, China. Int J Cancer 1985; 36: 545-47.
11. Raab Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986; 47: 883-89.
12. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995; 333: 693-98.
13. Simons MJ, Wee GB, Goh EH, et al. Immunogenetic aspects of nasopharyngeal carcinoma. IV. Increased risk in Chinese of nasopharyngeal carcinoma associated with a Chinese-related HLA profile (A2, Singapore2). J Natl Cancer Inst 1976; 57: 977-80.
14. Huang DP, Lo K-W, van Hasselt CA, et al. A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma. Cancer Res 1994; 54: 4003-06.
15. Feinmesser R, Miyazai I, Cheung R, et al. Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration. N Engl J Med 1992; 326: 17-21.
16. Olmi P, Cellai E, Chiavacci A, Fallai C, Giannardi G, Fargnoli R, Vilari N. Computed tomography in nasopharyngeal carcinoma: part I: T-stage conversion with CT-staging. Int J Radiat Oncol Biol Phys 1990; 19: 1171-75.
17. Perez CA, Devineni VR, Marciai-Vega V, Marks JE, Simpson JR, Kucik N. Carcinoma of the nasopharynx: factors affecting prognosis. Int J Radiat Oncol Biol Phys 1992; 23: 271-80.
18. Bedwinek JM, Perez CA. Carcinoma of the nasopharynx. In: Perez CA, Brady LW, eds. Principles and Practice of Radiation Oncology. Philadelphia: Lippincott, 1987; 479-98.
19. Vikram B, Strong WE, Manolatos S, Mishra UB. Improved survival in carcinoma of the nasopharynx. 1984; Head Neck Surg 7: 123-28.
20. Lee AWM, Poon YF, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1975-1985: overall survival and patterns of failure. Int J Rad Oncol Biol Phys 1992; 23: 261-70.
21. Wang CC. Improved local control of nasopharyngeal carcinoma after intracavitary brachtherapy boost. Am J Clin Oncol (CCT) 1991; 14: 5-8.
22. Sanguineti G, Geara FB, Garden AS, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: detriments of local and regional control. Int J Radiat Oncol Biol Phys 1997; 37: 985-96.
23. Tannock I, Payne D, Cummings B, Hewitt K, Panzarella T. Sequential chemotherapy and radiation for nasopharyngeal cancer: absence of long-term benefit despite a high rate of tumor response to chemotherapy. J Clin Oncol 1987; 5: 629-34.
24. Garden AS, Lippman SM, Morrison WH, Gilsson BS, Ang KK, Geara F, Hong WK, Peters LJ. Does induction chemotherapy have a role in the management of nasopharyngeal carcinoma? Results of treatment in the era of computerized tomography. Int J Radiat Oncol Biol Phys 1996; 36: 1005-12.
25. International Nasopharynx Cancer Study Group: VUMCA I Trial: Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs Radiotherapy alone in stage IV(≥N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. Int J Rad Oncol Biol Phys 1996; 35: 463-69.
26. Chan ATC, Teo PML, Leung TWT, et al. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1995; 33: 569-77.
27. Al-Sarraf M, LeBlanc M, Fu K, et al. Superiority of chemo-radiotherapy (CT-RT) vs radiotherapy in patients with locally advanced nasopharyngeal cancer (abstr). Am Soc Clin Oncol 1996; 15 (882): 313.
28. Boussen H, Cvitkovic E, Wendling JL, et al. Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin bleomycin, and fluorouracil. J Clin Oncol 1991; 9: 1675-81.
29. Wang CC. Re-irradiation of recurrent nasopharyngeal carcinoma-treatment techniques and results. Int J Radiation Oncology Biol Phys 1987; 13: 953-56.
30. Lee AWM, Foo W, Law SCK, et al. Reirradiation for recurrent nasopharyngeal carcinoma: factors affecting the therapeutic ratio and ways for improvement. Int J Radiat Oncol Biol Phys 1997; 38: 43-52.